EBOS Group Limited Share Price OTC Markets
Stocks
EBOSY
US2787271020
Pharmaceuticals
OTC Markets Traded|
Delayed
OTC Markets
21:01:31 21/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 23.00 USD | +16.99% |
|
+16.99% | -34.34% |
| 10-21 | EBOS Group Limited - Shareholder/Analyst Call | |
| 09-09 | EBOS Group Declares Strike Price for Shares under Dividend Reinvestment Plan | MT |
| Market Cap | 3.52B 2.47B 2.21B 2.04B 1.85B 3.47B 234B 24.52B 9.66B 123B 9.28B 9.08B 389B | P/E 2027 * |
15.1x | P/E 2028 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 4.53B 3.18B 2.84B 2.62B 2.38B 4.47B 301B 31.57B 12.43B 158B 11.94B 11.69B 500B | EV / Sales 2027 * |
0.32x | EV / Sales 2028 * | 0.31x |
| Free-Float |
90.79% | Yield 2027 * |
5.54% | Yield 2028 * | 6.1% |
Last Transcript: EBOS Group Limited
| 1 day | +16.99% | ||
| 1 week | +16.99% | ||
| Current month | -1.29% | ||
| 1 month | -1.29% | ||
| 3 months | -11.54% | ||
| 6 months | -12.94% | ||
| Current year | -34.34% |
| 1 week | 23 |  | 23 |
| 1 month | 19.66 | | 23 |
| Current year | 19.66 | | 46.64 |
| 1 year | 19.66 | | 46.64 |
| 3 years | 19.66 | | 47.23 |
| 5 years | 19.66 | | 47.23 |
| 10 years | 19.66 | | 47.23 |
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Hall
CEO | Chief Executive Officer | 51 | 30/06/2025 |
Alistair Gray
DFI | Director of Finance/CFO | - | 29/09/2024 |
Andrew McLean
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Liz Coutts
CHM | Chairman | 66 | - |
| Director/Board Member | - | 30/06/2019 | |
Tracey Batten
BRD | Director/Board Member | 60 | 30/06/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +16.99% | +16.99% | - | - | 2.48B | |
| +2.93% | +4.72% | +61.34% | +127.30% | 1,133B | |
| +4.14% | +6.16% | +39.36% | +77.61% | 621B | |
| -0.15% | +0.44% | +24.47% | +96.67% | 503B | |
| +0.03% | +3.27% | +39.79% | +65.06% | 379B | |
| -1.73% | +1.95% | +68.95% | +43.22% | 370B | |
| +1.58% | +2.37% | +22.91% | +52.52% | 292B | |
| +2.90% | +2.22% | +3.51% | +28.51% | 262B | |
| +2.23% | +3.29% | +51.46% | +64.17% | 237B | |
| +2.11% | -0.27% | +29.22% | +102.35% | 190B | |
| Average | +3.10% | +3.22% | +37.89% | +73.05% | 443.11B | |
| Weighted average by Cap. | +1.85% | +3.73% | +43.18% | +85.06% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 14.03B 9.84B 8.78B 8.1B 7.36B 13.81B 932B 97.63B 38.46B 488B 36.94B 36.15B 1,547B | 14.64B 10.27B 9.17B 8.46B 7.69B 14.42B 973B 102B 40.14B 510B 38.56B 37.73B 1,615B |
| Net income | 228M 160M 143M 132M 119M 224M 15.13B 1.58B 624M 7.93B 599M 587M 25.11B | 263M 185M 165M 152M 138M 259M 17.5B 1.83B 722M 9.17B 694M 679M 29.05B |
| Net Debt | 1.01B 711M 634M 585M 532M 998M 67.32B 7.05B 2.78B 35.27B 2.67B 2.61B 112B | 974M 684M 610M 563M 512M 960M 64.76B 6.78B 2.67B 33.93B 2.57B 2.51B 107B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EBO Stock
- EBOSY Stock
Select your edition
All financial news and data tailored to specific country editions
